To include your compound in the COVID-19 Resource Center, submit it here.

Hyperion, Medicis deal

Hyperion acquired worldwide rights to Ravicti glycerol phenylbutyrate ( HPN-100) from Medicis' Ucyclyd Pharma Inc. subsidiary. The

Read the full 175 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE